Reviews
Systematic reviews
Search a topic, title, author or review id. The Findings tab shows what the reviews found for the same words, grouped by question; the Studies tab shows the primary studies they include.
11 reviews, newest first
Acetylcholinesterase inhibitors for autistic spectrum disorders
Cochraneheadline outcomes only
14 findings
Phosphodiesterase 5 inhibitors (PDE5i) for the treatment of Raynaud's phenomenon
Cochraneheadline outcomes only
7 findings
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia
Cochraneheadline outcomes only
13 findings
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta‐analysis
Cochraneheadline outcomes only
19 findings
Phosphodiesterase‐4 inhibitors for chronic obstructive pulmonary disease
Cochraneheadline outcomes only
9 findings
Phosphodiesterase 5 inhibitors for pulmonary hypertension
Cochraneheadline outcomes only
54 findings
Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
Cochraneheadline outcomes only
18 findings
Cholinesterase inhibitors for the treatment of delirium in non‐ICU settings
Cochraneheadline outcomes only
7 findings
Cholinesterase inhibitors for rarer dementias associated with neurological conditions
Cochraneheadline outcomes only
22 findings
Acetylcholinesterase inhibitor treatment for myasthenia gravis
Cochraneheadline outcomes only
3 findings
Acetylcholinesterase inhibitors for schizophrenia
Cochraneheadline outcomes only
7 findings